Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharma Mar SA (ES:PHM)
BME:PHM
Holding ES:PHM?
Track your performance easily
See the Price Targets and Ratings of:
PHM Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PHM Stock 12 Month Forecast
Average Price Target
€48.00
▼(-36.55% Downside)
| Highest Price Target€48.00 | Average Price Target€48.00 | Lowest Price Target€48.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Chardan Capital
Initiated
08/01/24
―
Oddo BHF
―
Hold
―
Downgraded
10/07/24
Pharma Mar downgraded to Neutral from Outperform at Oddo BHFPharma Mar downgraded to Neutral from Outperform at Oddo BHF
Best Analysts Covering Pharma Mar SA
Which Analyst Should I Follow If I Want to Buy ES:PHM and Sell After:
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
+3.08%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.08% per trade.
3 Months
xxx
Success Rate
3/4 ratings generated profit
Average Return
+10.60%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +10.60% per trade.
1 Year
2 Years
xxx
Success Rate
3/4 ratings generated profit
Average Return
+44.70%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +44.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PHM Analyst Recommendation Trends
Rating
Jan 23
Apr 23
Apr 24
Aug 24
Oct 24
Strong Buy
0
0
1
1
1
Buy
5
5
2
2
1
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
PHM Financial Forecast
PHM Stock Forecast FAQ
What is ES:PHM’s average 12-month price target, according to analysts?
Based on analyst ratings, Pharma Mar SA’s 12-month average price target is €48.00.
What is ES:PHM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ES:PHM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pharma Mar SA a Buy, Sell or Hold?
Pharma Mar SA has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Pharma Mar SA’s share price target?
The average share price target for Pharma Mar SA is €48.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €48.00 ,and the lowest forecast is €48.00. The average share price target represents -36.55% Decrease from the current price of €75.65.
The highest analyst share price target is €48.00 ,and the lowest forecast is €48.00. The average share price target represents -36.55% Decrease from the current price of €75.65.
What do analysts say about Pharma Mar SA?
Pharma Mar SA’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Pharma Mar SA?
To buy shares of ES:PHM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.